K092552 is an FDA 510(k) clearance for the CLO-SURPLUS P.A.D.. Classified as Hemostatic Wound Dressing Without Thrombin Or Other Biologics (product code QSY).
Submitted by Scion Cardio-Vascular, Inc. (Miami, US). The FDA issued a Cleared decision on September 4, 2009 after a review of 15 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Scion Cardio-Vascular, Inc. devices